• Phosbind Biotin LC: Practical Phosphoprotein Detection

  2026-08-14

  Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes when a suitable phospho-specific antibody is unavailable or insufficient. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, not aqueous-only protocols or long-term storage of working solutions.

• ACE Inhibitor Selectivity Across Aminopeptidases

  2026-08-14

  Tieku and Hooper re-evaluated the selectivity of bestatin and several metallopeptidase inhibitors against three porcine kidney cell-surface aminopeptidases. Their comparative analysis showed that inhibitor behavior varied substantially among aminopeptidase A, N, and W, providing an important framework for interpreting off-target activity in ACE inhibitor and peptide-metabolism studies.

• Pyridostigmine, α7nAChR, and Placental Necroptosis

  2026-08-13

  This study identifies placental necroptosis as a modifiable component of placental ischemia in a rat model of preeclampsia-like disease. Its antagonist and inhibitor experiments suggest that pyridostigmine acts through α7 nicotinic acetylcholine receptor signaling to reduce necroptosis, inflammation, oxidative stress, and maternal hypertension.

• LEE011 Succinate: A Mechanism-First Assay Guide

  2026-08-13

  Explore LEE011 succinate as a CDK inhibitor through a mechanism-first framework for cell cycle regulation and cancer research. This guide connects target engagement, orthogonal phenotyping, formulation variables, and insights from an EV71 antiviral study without conflating distinct biological mechanisms.

• Linoleic Acid–PPARα–TF Signaling in pLELC

  2026-08-12

  This reference study combines proteomics, metabolomics, functional perturbation, and patient-derived xenograft validation to identify a linoleic acid–PPARα–tissue factor axis in primary pulmonary lymphoepithelioma-like carcinoma. The findings connect altered lipid handling with immune-cell remodeling and support tissue factor as a candidate therapeutic target, while also defining important limits for translating the mechanism into other PPARα research settings.

• Partial BACE1 Inhibition and Synaptic Function

  2026-08-12

  Satir et al. examined whether reducing amyloid-beta production through partial BACE inhibition disrupts neuronal communication. Using optical electrophysiology in primary rat cortical cultures, the study found that moderate inhibition, producing less than a 50% reduction in secreted amyloid-beta, preserved synaptic transmission, whereas stronger inhibition impaired it.

• α-Bungarotoxin: From Blockade to Translation

  2026-08-11

  α-Bungarotoxin is more than a receptor antagonist: it is a causal tool for testing whether α7 nicotinic acetylcholine receptor signaling drives phenotypes across neural and non-neural systems. This thought-leadership article examines its mechanistic value, experimental use, translational boundaries, and strategic role in studies of cholinergic signaling and placental necroptosis.

• Propranolol: Metabolic and β-Blockade Workflows

  2026-08-11

  Propranolol enables integrated studies of β1/β2 signaling, cardiovascular regulation, emotional memory modulation, and post-injury metabolism. This practical guide translates burn-metabolism findings into reproducible stock-preparation, tissue-analysis, assay-design, and troubleshooting workflows.

• Perospirone: From Receptors to Vascular Kv1.5

  2026-08-10

  Perospirone and SM-9018 free base combine serotonergic–dopaminergic receptor activity with a newly characterized vascular Kv-channel effect. This article explains how to separate therapeutic pharmacology from concentration-dependent off-target findings when designing schizophrenia research and cardiovascular assays.

• Intranasal Epinephrine in Dogs: PK and Heart Rate

  2026-08-09

  The reference study evaluated intranasal epinephrine as an alternative to intramuscular delivery in dogs, combining plasma pharmacokinetics with heart-rate monitoring. Its key finding was that intranasal administration produced a rapid early plasma exposure and a smaller heart-rate response than intramuscular dosing, while showing broadly comparable overall exposure at selected dose pairs.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-08

  The Tricine-SDS-PAGE Gel Preparation Kit is intended for high-resolution protein electrophoresis and peptide separation in the low-molecular-weight range, including targets that are difficult to resolve with conventional Tris-glycine systems. It is for scientific research use only and should not be used for diagnostic, clinical, or medical applications.

• 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine

  2026-08-07

  Use this research-grade α2-adrenergic receptor agonist to separate direct osteosarcoma-cell effects from immune-mediated tumor control. Its DMSO compatibility supports reproducible cell, signaling, and thermo-sensitive hydrogel workflows for post-surgical recurrence studies.

• Circular IL-23 mRNA and MSA-2-Pt: Synergy in Tumor Immunothe

  2026-08-07

  A recent study demonstrated that delivering circular IL-23 mRNA via lipid nanoparticles, combined with platinum-modified STING agonist MSA-2, markedly improves antitumor efficacy in melanoma models. This approach extends IL-23 half-life, sustains immune activation, and highlights the promise of combinatorial mRNA and small-molecule strategies for next-generation cancer immunotherapy.

• Precision HIF Stabilization: Molidustat for Translational An

  2026-08-06

  This thought-leadership article explores how Molidustat (BAY85-3934) empowers translational researchers to redefine anemia therapy by leveraging hypoxia-inducible factor (HIF) stabilization. Integrating mechanistic insight into the VHL-mediated degradation of HIF-1α, the article outlines practical guidance for preclinical and translational workflows, evaluates the competitive landscape, and articulates the clinical promise of HIF-PH inhibitors in chronic kidney disease anemia. Drawing from the latest evidence, including the role of Septin4 in cardiomyocyte apoptosis, the discussion highlights how APExBIO's Molidustat sets a new standard for experimental control and reliability.

• Apicidin as a Selective HDAC Inhibitor: Mechanistic Depth an

  2026-08-06

  Discover the multifaceted scientific utility of Apicidin, a potent histone deacetylase inhibitor, with advanced mechanistic insight and protocol guidance for cancer and reproductive research. This article uniquely explores both the molecular consequences and practical considerations for experimental design.

16025 records 1/1069 page Next 12345 下5页 Last page